Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Enteropathy-Associated T-Cell Lymphoma × Nivolumab × 90 days × Clear all

Sponsor

Conditions

Melanoma 57 Carcinoma, Non-Small-Cell Lung 49 Carcinoma, Renal Cell 32 Lung Neoplasms 25 Neoplasm Metastasis 22 Colorectal Neoplasms 18 Stomach Neoplasms 17 Neoplasms 17 Carcinoma, Hepatocellular 17 Squamous Cell Carcinoma of Head and Neck 15 Carcinoma, Transitional Cell 14 Urinary Bladder Neoplasms 12 Adenocarcinoma Of Esophagus 12 Skin Neoplasms 11 Prostatic Neoplasms 9 Rectal Neoplasms 8 Ovarian Neoplasms 8 Esophageal Neoplasms 8 Colonic Neoplasms 8 Breast Neoplasms 8 Brain Neoplasms 8 Uveal Melanoma 7 Multiple Myeloma 7 Hodgkin Disease 7 Carcinoma, Merkel Cell 7 Urethral Neoplasms 6 Thyroid Neoplasms 6 Sarcoma 6 Recurrence 6 Small Cell Lung Carcinoma 5

Interventions

Cyclophosphamide 3 Vincristine 2 Prednisone 2 Etoposide 2 Doxorubicin 2 tazemetostat 1 fludarabine 1 etoposide phosphate 1 duvelisib 1 Prednisolone 1 Melphalan 1 Cytarabine 1 Carmustine 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡